Literature DB >> 11235857

Ten year progressive ventricular enlargement in schizophrenia: an MRI morphometrical study.

T Saijo1, T Abe, Y Someya, T Sassa, Y Sudo, T Suhara, T Shuno, K Asai, Y Okubo.   

Abstract

Recent studies of the brain using magnetic resonance imaging (MRI) have suggested progressive structural changes in schizophrenics. However, those studies were conducted over periods of less than 5 years and thus lacked sufficient capacity to determine the course and nature of this process. In this study, MRI scans were obtained in 15 schizophrenics and 12 controls at baseline and after 4- and 10-year follow ups. Volumes of the lateral ventricles were measured. Patients were assessed by the Brief Psychiatric Rating Scale (BPRS) at the same two time points: at baseline and at 10-year follow up. After 10 years, a significant lateral ventricular enlargement was found in patients (mean percentage change: +22.9%) but not in controls (5.1%). Although our results are not in disagreement with the neurodevelopmental hypothesis, they do provide strong evidence that in schizophrenia progressive brain reduction occurs even in its chronic stage.

Entities:  

Mesh:

Year:  2001        PMID: 11235857     DOI: 10.1046/j.1440-1819.2001.00783.x

Source DB:  PubMed          Journal:  Psychiatry Clin Neurosci        ISSN: 1323-1316            Impact factor:   5.188


  16 in total

Review 1.  [Changes in brain structure caused by neuroleptic medication].

Authors:  H Scherk; P Falkai
Journal:  Nervenarzt       Date:  2004-11       Impact factor: 1.214

Review 2.  Differential aging of the brain: patterns, cognitive correlates and modifiers.

Authors:  Naftali Raz; Karen M Rodrigue
Journal:  Neurosci Biobehav Rev       Date:  2006-08-17       Impact factor: 8.989

Review 3.  The concept of progressive brain change in schizophrenia: implications for understanding schizophrenia.

Authors:  Lynn E DeLisi
Journal:  Schizophr Bull       Date:  2008-02-08       Impact factor: 9.306

4.  Choroid Plexus Enlargement and Allostatic Load in Schizophrenia.

Authors:  Yan-Fang Zhou; Jun-Chao Huang; Ping Zhang; Feng-Mei Fan; Song Chen; Hong-Zhen Fan; Yi-Min Cui; Xing-Guang Luo; Shu-Ping Tan; Zhi-Ren Wang; Wei Feng; Ying Yuan; Fu-De Yang; Anya Savransky; Meghann Ryan; Eric Goldwaser; Joshua Chiappelli; Laura M Rowland; Peter Kochunov; Yun-Long Tan; L Elliot Hong
Journal:  Schizophr Bull       Date:  2020-04-10       Impact factor: 9.306

Review 5.  Neurobiological background of negative symptoms.

Authors:  Silvana Galderisi; Eleonora Merlotti; Armida Mucci
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2015-03-24       Impact factor: 5.270

Review 6.  What happens after the first episode? A review of progressive brain changes in chronically ill patients with schizophrenia.

Authors:  Hilleke E Hulshoff Pol; René S Kahn
Journal:  Schizophr Bull       Date:  2008-02-17       Impact factor: 9.306

7.  Molecular profiles of schizophrenia in the CNS at different stages of illness.

Authors:  Sujatha Narayan; Bin Tang; Steven R Head; Timothy J Gilmartin; J Gregor Sutcliffe; Brian Dean; Elizabeth A Thomas
Journal:  Brain Res       Date:  2008-08-16       Impact factor: 3.252

8.  A prospective longitudinal volumetric MRI study of superior temporal gyrus gray matter and amygdala-hippocampal complex in chronic schizophrenia.

Authors:  Takeshi Yoshida; Robert W McCarley; Motoaki Nakamura; KangUk Lee; Min-Seong Koo; Sylvain Bouix; Dean F Salisbury; Lindsay Morra; Martha E Shenton; Margaret A Niznikiewicz
Journal:  Schizophr Res       Date:  2009-06-13       Impact factor: 4.939

9.  Neurodevelopmental impairment, dopamine sensitisation, and social adversity in schizophrenia.

Authors:  Robin M Murray; Colm McDonald; Elvira Bramon
Journal:  World Psychiatry       Date:  2002-10       Impact factor: 49.548

Review 10.  Progressive loss of cortical gray matter in schizophrenia: a meta-analysis and meta-regression of longitudinal MRI studies.

Authors:  A Vita; L De Peri; G Deste; E Sacchetti
Journal:  Transl Psychiatry       Date:  2012-11-20       Impact factor: 6.222

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.